Drug
Daikenchuto (TU-100)
Daikenchuto (TU-100) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy
NCT02232893
completedphase_1
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
NCT01890837
completedphase_2
Effect of TU-100 in Patients With Functional Constipation
NCT01348152
completedphase_1
Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation
NCT01139216
completedphase_1
Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans
NCT00871325
Clinical Trials (5)
Showing 5 of 5 trials
NCT02232893Phase 2
Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy
NCT01890837Phase 1
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
NCT01348152Phase 2
Effect of TU-100 in Patients With Functional Constipation
NCT01139216Phase 1
Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation
NCT00871325Phase 1
Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5